Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Uncovering potential host proteins and pathways that may interact with eukaryotic short linear motifs in viral proteins of MERS, SARS and SARS2 coronaviruses that infect humans. | PLoS One | 2021 | 33534852 | PubTator, text mining | PubMed |
| Multiplexed single-cell mass cytometry reveals distinct inhibitory effects on intracellular phosphoproteins by midostaurin in combination with chemotherapy in AML cells. | Exp Hematol Oncol | 2021 | 33531064 | PubTator, text mining | PubMed |
| The Interactions of DNA Repair, Telomere Homeostasis, and p53 Mutational Status in Solid Cancers: Risk, Prognosis, and Prediction. | Cancers (Basel) | 2021 | 33513745 | PubTator, text mining | PubMed |
| Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. | Arch Toxicol | 2021 | 33512557 | PubTator, text mining | PubMed |
| EMT-associated microRNAs and their roles in cancer stemness and drug resistance. | Cancer Commun (Lond) | 2021 | 33506604 | PubTator, text mining | PubMed |
| Use of Network Pharmacology to Investigate the Mechanism by Which Allicin Ameliorates Lipid Metabolism Disorder in HepG2 Cells. | Evid Based Complement Alternat Med | 2021 | 33505493 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Prediction of Catalpol and Mechanisms against Stroke. | Evid Based Complement Alternat Med | 2021 | 33505489 | PubTator, text mining | PubMed |
| Diversity and versatility of p38 kinase signalling in health and disease. | Nat Rev Mol Cell Biol | 2021 | 33504982 | PubTator, text mining | PubMed |
| Aryl Hydrocarbon Receptor Signaling Controls CD155 Expression on Macrophages and Mediates Tumor Immunosuppression. | J Immunol | 2021 | 33504618 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. | J Immunother Cancer | 2021 | 33504575 | PubTator, text mining | PubMed |
| A Fbxo48 inhibitor prevents pAMPKα degradation and ameliorates insulin resistance. | Nat Chem Biol | 2021 | 33495648 | PubTator, text mining | PubMed |
| Property-Unmatched Decoys in Docking Benchmarks. | J Chem Inf Model | 2021 | 33494610 | PubTator, text mining | PubMed |
| The Jekyll and Hyde of Cellular Senescence in Cancer. | Cells | 2021 | 33494247 | PubTator, text mining | PubMed |
| Pro-Resolving FPR2 Agonists Regulate NADPH Oxidase-Dependent Phosphorylation of HSP27, OSR1, and MARCKS and Activation of the Respective Upstream Kinases. | Antioxidants (Basel) | 2021 | 33477989 | PubTator, text mining | PubMed |
| Topsentinol L Trisulfate, a Marine Natural Product That Targets Basal-like and Claudin-Low Breast Cancers. | Mar Drugs | 2021 | 33477536 | PubTator, text mining | PubMed |
| Formation and Function of Liquid-Like Viral Factories in Negative-Sense Single-Stranded RNA Virus Infections. | Viruses | 2021 | 33477448 | PubTator, text mining | PubMed |
| MIND bomb 2 prevents RIPK1 kinase activity-dependent and -independent apoptosis through ubiquitylation of cFLIPL. | Commun Biol | 2021 | 33469115 | PubTator, text mining | PubMed |
| Osteoarthritis In Vitro Models: Applications and Implications in Development of Intra-Articular Drug Delivery Systems. | Pharmaceutics | 2021 | 33466397 | PubTator, text mining | PubMed |
| The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV. | Arch Virol | 2021 | 33462671 | PubTator, text mining | PubMed |
| Cryptosporidial Infection Suppresses Intestinal Epithelial Cell MAPK Signaling Impairing Host Anti-Parasitic Defense. | Microorganisms | 2021 | 33445463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=49